Table 3.
Patients’ Demography by Histological Type, Stage, Surgery, Chemotherapy, Maternal and Perinatal Outcome
| BOT (n=41) | EOC (n=18) | MOGCT (n=14) | MSCT (n=2) | SCLC (n=1) | Metastatic Carcinoma (n=9) | Total (%) | |
|---|---|---|---|---|---|---|---|
| FIGO stage | |||||||
| I | 41 | 10 | 14 | 2 | – | – | 67 (78.82) |
| II | – | 2 | – | – | – | – | 2 (2.35) |
| III | – | 6 | – | – | 1 | – | 7 (8.23) |
| IV | – | – | – | – | – | 9 | 9 (10.59) |
| Surgery | |||||||
| Conservative surgerya | 26 | 4 | 3 | 1 | – | 2 | 36 (42.35) |
| Fertility-sparing surgery | 13 | 6 | 9 | 1 | – | 5 | 34 (40.00) |
| Radical surgery | 2 | 8 | 2 | – | 1 | 2 | 15 (17.65) |
| Chemotherapy | |||||||
| Yes | 1 | 13 | 9 | – | – | 5 | 28 (32.94) |
| No | 40 | 4 | 5 | 2 | – | – | 51 (60.00) |
| Missing | – | 1 | – | – | 1 | 4 | 6 (7.06) |
| Pregnancy outcome | |||||||
| Abortion | 8 | 1 | 5 | – | 1 | 3 | 18 (21.18) |
| Live birth | 33 | 17 | 9 | 2 | – | 6 | 67 (78.82) |
| Maternal outcome | |||||||
| DFS | 38 | 14 | 12 | 2 | – | – | 66 (77.65) |
| Recurrence | 2 | 1 | 1 | – | – | 1 | 5 (5.88) |
| DOD | – | 1 | – | – | – | 4 | 5 (5.88) |
| Missing | 1 | 2 | 1 | – | 1 | 4 | 9 (10.59) |
Note: acystectomy or unilateral salpingo-oophorectomy merely without staging.
Abbreviations: BOT, borderline ovarian tumor; EOC, epithelial ovarian cancer; MOGCT, malignant ovarian germ cell tumors; MSCT, malignant sex cord-stromal tumors; SCLC, small cell carcinoma; DOD, death of disease; DFS, disease-free survival.